Structure-based Virtual Screening and Hit Identification of Novel designed Quinazolin-4(3H)-one Derivatives as Antitubercular Agent Against targets Polyketide Synthase 13 and DNA gyrase of Mycobacterium tuberculosis
{{output}}
Background: After COVID-19, tuberculosis remained the world's second most infectious fatal disease in 2022, with about 410 million people developing MDR TB, according to WHO. The fast increase of MDR and XDR-TB has posed a signi... ...
